{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:16:16Z","timestamp":1790730976307,"version":"4.1.0"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00702-025-02994-0","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T06:19:47Z","timestamp":1754029187000},"page":"1705-1717","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Update on sleep disorders in advanced Parkinson\u2019s disease: a narrative review"],"prefix":"10.1007","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9727-3459","authenticated-orcid":false,"given":"Emmanuel","family":"Roze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Rudzinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tove","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eero","family":"Pekkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Minar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Druzdz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Biering-S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smaranda","family":"Leu-Semenescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"2994_CR1","doi-asserted-by":"publisher","DOI":"10.31083\/J.JIN2304080","author":"T Abdul-Rahman","year":"2024","unstructured":"Abdul-Rahman T, Herrera-Calder\u00f3n RE, Aderinto N et al (2024) Clearing the fog: a review of antipsychotics for parkinson\u2019s-related hallucinations: a focus on pimavanserin, quetiapine and clozapine. J Integr Neurosci. https:\/\/doi.org\/10.31083\/J.JIN2304080","journal-title":"J Integr Neurosci"},{"key":"2994_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6621991","author":"L Ag\u00fcera-Ortiz","year":"2021","unstructured":"Ag\u00fcera-Ortiz L, Garc\u00eda-Ramos R, Grandas P\u00e9rez FJ et al (2021) Focus on depression in Parkinson\u2019s disease: a Delphi consensus of experts in psychiatry, neurology, and geriatrics. Parkinsons Dis https:\/\/doi.org\/10.1155\/2021\/6621991","journal-title":"Parkinsons Dis"},{"key":"2994_CR3","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/S40120-023-00533-1","volume":"12","author":"J Aldred","year":"2023","unstructured":"Aldred J, Freire-Alvarez E, Amelin AV et al (2023) Continuous subcutaneous foslevodopa\/foscarbidopa in parkinson\u2019s disease: safety and efficacy results from a 12-Month, Single-Arm, Open-Label, phase 3 study. Neurol Ther 12:1937\u20131958. https:\/\/doi.org\/10.1007\/S40120-023-00533-1","journal-title":"Neurol Ther"},{"key":"2994_CR4","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/J.SLEEP.2014.03.025","volume":"15","author":"RP Allen","year":"2014","unstructured":"Allen RP, Picchietti DL, Garcia-Borreguero D et al (2014) Restless legs syndrome\/Willis\u2013Ekbom disease diagnostic criteria: updated international restless legs syndrome study group (IRLSSG) consensus criteria history, rationale, description, and significance. Sleep Med 15:860\u2013873. https:\/\/doi.org\/10.1016\/J.SLEEP.2014.03.025","journal-title":"Sleep Med"},{"key":"2994_CR5","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.3233\/JPD-230227","volume":"14","author":"NE Allen","year":"2024","unstructured":"Allen NE, Romaliiska O, Naisby J (2024) Pain and the Non-Pharmacological management of pain in people with parkinson\u2019s disease. J Parkinsons Dis 14:S65\u2013S80. https:\/\/doi.org\/10.3233\/JPD-230227","journal-title":"J Parkinsons Dis"},{"key":"2994_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/S10072-024-07659-6","author":"AZ Alnajjar","year":"2024","unstructured":"Alnajjar AZ, Abouelmagd ME, Krayim A et al (2024) Efficacy of cognitive behavioral therapy for anxiety and depression in Parkinson\u2019s disease patients: an updated systematic review and meta-analysis. Neurol Sci. https:\/\/doi.org\/10.1007\/S10072-024-07659-6","journal-title":"Neurol Sci"},{"key":"2994_CR7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1136\/JNNP-2016-315023","volume":"88","author":"AW Amara","year":"2017","unstructured":"Amara AW, Chahine LM, Caspell-Garcia C et al (2017) Longitudinal assessment of excessive daytime sleepiness in early parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 88:653\u2013662. https:\/\/doi.org\/10.1136\/JNNP-2016-315023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2994_CR8","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.23F15009","author":"C Andrade","year":"2023","unstructured":"Andrade C (2023) Cholinesterase inhibitors for delusions and hallucinations in Alzheimer disease and Parkinson disease: questionably significant benefits. J Clin Psychiatry. https:\/\/doi.org\/10.4088\/JCP.23F15009","journal-title":"J Clin Psychiatry"},{"key":"2994_CR9","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1734-1140(13)71038-7","volume":"65","author":"JM Antczak","year":"2013","unstructured":"Antczak JM, Rakowicz MJ, Banach M et al (2013) Negative influence of L-dopa on subjectively assessed sleep but not on nocturnal polysomnography in parkinson\u2019s disease. Pharmacol Rep 65:614\u2013623. https:\/\/doi.org\/10.1016\/S1734-1140(13)71038-7","journal-title":"Pharmacol Rep"},{"key":"2994_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/MDC3.14254","volume":"12","author":"E Antelmi","year":"2025","unstructured":"Antelmi E, Lanza G, Mogavero MP et al (2025) Intersection of sleep disorders and Parkinson disease: unveiling the bidirectional relationship. Mov Disord Clin Pract 12:11\u201320. https:\/\/doi.org\/10.1002\/MDC3.14254","journal-title":"Mov Disord Clin Pract"},{"key":"2994_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1212\/WNL.55.2.281","volume":"55","author":"I Arnulf","year":"2000","unstructured":"Arnulf I, Bonnet AM, Damier P et al (2000) Hallucinations, REM sleep, and parkinson\u2019s disease: a medical hypothesis. Neurology 55:281\u2013288. https:\/\/doi.org\/10.1212\/WNL.55.2.281","journal-title":"Neurology"},{"key":"2994_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/JSR.14453","author":"Z Asadpoordezaki","year":"2025","unstructured":"Asadpoordezaki Z, Henley BM, Coogan AN (2025) Prevalence and associations of self-reported sleep problems in a large sample of patients with Parkinson\u2019s disease. J Sleep Res. https:\/\/doi.org\/10.1111\/JSR.14453","journal-title":"J Sleep Res"},{"key":"2994_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2174\/1570159X17666191016094857","volume":"18","author":"F Assogna","year":"2019","unstructured":"Assogna F, Pellicano C, Savini C et al (2019) Drug choices and advancements for managing depression in parkinson\u2019s disease. Curr Neuropharmacol 18:277\u2013287. https:\/\/doi.org\/10.2174\/1570159X17666191016094857","journal-title":"Curr Neuropharmacol"},{"key":"2994_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(10)70106-X","volume":"9","author":"P Barone","year":"2010","unstructured":"Barone P, Poewe W, Albrecht S et al (2010) Pramipexole for the treatment of depressive symptoms in patients with parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 9:573\u2013580. https:\/\/doi.org\/10.1016\/S1474-4422(10)70106-X","journal-title":"Lancet Neurol"},{"key":"2994_CR15","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1016\/j.parkreldis.2016.11.016","volume":"33","author":"R Bhidayasiri","year":"2016","unstructured":"Bhidayasiri R, Sringean J, Anan C et al (2016) Quantitative demonstration of the efficacy of night-time apomorphine infusion to treat nocturnal hypokinesia in parkinson\u2019s disease using wearable sensors. Parkinsonism Relat Disord 33:S36\u2013S41. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.11.016","journal-title":"Parkinsonism Relat Disord"},{"key":"2994_CR16","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/S40266-023-01065-X","volume":"40","author":"N Bittner","year":"2023","unstructured":"Bittner N, Funk CSM, Schmidt A et al (2023) Psychiatric adverse events of acetylcholinesterase inhibitors in alzheimer\u2019s disease and parkinson\u2019s dementia: systematic review and Meta-Analysis. Drugs Aging 40:953\u2013964. https:\/\/doi.org\/10.1007\/S40266-023-01065-X","journal-title":"Drugs Aging"},{"key":"2994_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0167-4943(00)00087-X","volume":"32","author":"M Caap-Ahlgren","year":"2001","unstructured":"Caap-Ahlgren M, Dehlin O (2001) Insomnia and depressive symptoms in patients with parkinson\u2019s disease: relationship to health-related quality of life. An interview study of patients living at home. Arch Gerontol Geriatr 32:23\u201333. https:\/\/doi.org\/10.1016\/S0167-4943(00)00087-X","journal-title":"Arch Gerontol Geriatr"},{"key":"2994_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/SLEEP\/ZSAB257","author":"M Cesari","year":"2022","unstructured":"Cesari M, Group for the IRS, Heidbreder A et al (2022) Video-polysomnography procedures for diagnosis of rapid eye movement sleep behavior disorder (RBD) and the identification of its prodromal stages: guidelines from the International RBD Study Group. Sleep. https:\/\/doi.org\/10.1093\/SLEEP\/ZSAB257","journal-title":"Sleep"},{"key":"2994_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.18502\/cjn.v23i1.16431","volume":"23","author":"A Chitsaz","year":"2024","unstructured":"Chitsaz A, Najafi MR, Habibi F, Amirhajloo S (2024) Comparison of the effectiveness of modafinil and methylphenidate in treatment of excessive daytime sleepiness in patients with parkinson\u2019s disease. Curr J Neurol 23:39. https:\/\/doi.org\/10.18502\/cjn.v23i1.16431","journal-title":"Curr J Neurol"},{"key":"2994_CR20","doi-asserted-by":"publisher","first-page":"101384","DOI":"10.1016\/J.SMRV.2020.101384","volume":"55","author":"J Cristini","year":"2021","unstructured":"Cristini J, Weiss M, De Las Heras B et al (2021) The effects of exercise on sleep quality in persons with parkinson\u2019s disease: A systematic review with meta-analysis. Sleep Med Rev 55:101384. https:\/\/doi.org\/10.1016\/J.SMRV.2020.101384","journal-title":"Sleep Med Rev"},{"key":"2994_CR21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jamaneurol.2023.1835","volume":"80","author":"E D\u2019Angremont","year":"2023","unstructured":"D\u2019Angremont E, Begemann MJH, Van Laar T, Sommer IEC (2023) Cholinesterase inhibitors for treatment of psychotic symptoms in alzheimer disease and Parkinson disease: a meta-analysis. JAMA Neurol 80:813\u2013823. https:\/\/doi.org\/10.1001\/jamaneurol.2023.1835","journal-title":"JAMA Neurol"},{"key":"2994_CR22","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/J.SLEEP.2014.09.014","volume":"16","author":"V De Cochen","year":"2015","unstructured":"De Cochen V, Benard-Serre N, Driss V et al (2015) Supine sleep and obstructive sleep apnea syndrome in parkinson\u2019s disease. Sleep Med 16:1497\u20131501. https:\/\/doi.org\/10.1016\/J.SLEEP.2014.09.014","journal-title":"Sleep Med"},{"key":"2994_CR23","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/MDC3.13799","volume":"10","author":"V De Cochen","year":"2023","unstructured":"De Cochen V, Dodet P, Leu-Semenescu S et al (2023) Night-Time apomorphine infusion: who are the best candidates?? Mov Disord Clin Pract 10:1192\u20131197. https:\/\/doi.org\/10.1002\/MDC3.13799","journal-title":"Mov Disord Clin Pract"},{"key":"2994_CR24","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/mds.24969","volume":"27","author":"VC De Cock","year":"2012","unstructured":"De Cock VC, Bayard S, Yu H et al (2012) Suggested immobilization test for diagnosis of restless legs syndrome in parkinson\u2019s disease. Mov Disord 27:743\u2013749. https:\/\/doi.org\/10.1002\/mds.24969","journal-title":"Mov Disord"},{"key":"2994_CR25","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S1474-4422(22)00085-0","volume":"21","author":"VC De Cock","year":"2022","unstructured":"De Cock VC, Dodet P, Leu-Semenescu S et al (2022) Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with parkinson\u2019s disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study. Lancet Neurol 21:428\u2013437. https:\/\/doi.org\/10.1016\/S1474-4422(22)00085-0","journal-title":"Lancet Neurol"},{"key":"2994_CR26","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1001\/JAMANEUROL.2018.0640","volume":"75","author":"E De Pablo-Fernandez","year":"2018","unstructured":"De Pablo-Fernandez E, Courtney R, Warner TT, Holton JL (2018) A histologic study of the circadian system in Parkinson disease, multiple system atrophy, and progressive supranuclear palsy. JAMA Neurol 75:1008\u20131012. https:\/\/doi.org\/10.1001\/JAMANEUROL.2018.0640","journal-title":"JAMA Neurol"},{"key":"2994_CR27","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1136\/JNNP.2006.100016","volume":"78","author":"D Devos","year":"2006","unstructured":"Devos D, Krystkowiak P, Clement F et al (2006) Improvement of gait by chronic, high doses of methylphenidate in patients with advanced parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 78:470. https:\/\/doi.org\/10.1136\/JNNP.2006.100016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2994_CR28","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3390\/JPM13071053","volume":"13","author":"\u015e Diaconu","year":"2023","unstructured":"Diaconu \u015e, Irincu L, Ungureanu L et al (2023) Nocturia and sleep in parkinson\u2019s disease. J Personalized Med 2023 13:1053. https:\/\/doi.org\/10.3390\/JPM13071053","journal-title":"J Personalized Med 2023"},{"key":"2994_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/S41531-024-00642-0","author":"P Dodet","year":"2024","unstructured":"Dodet P, Houot M, Leu-Semenescu S et al (2024a) Sleep disorders in Parkinson\u2019s disease, an early and multiple problem. NPJ Parkinson\u2019s Dis. https:\/\/doi.org\/10.1038\/S41531-024-00642-0","journal-title":"NPJ Parkinson\u2019s Dis"},{"key":"2994_CR30","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/MDS.29813","volume":"39","author":"P Dodet","year":"2024","unstructured":"Dodet P, Houot M, Leu-Semenescu S et al (2024b) Isolated REM sleep without Atonia is not equivalent to REM sleep behavior disorder in Early-Stage parkinson\u2019s disease. Mov Disord 39:1190\u20131202. https:\/\/doi.org\/10.1002\/MDS.29813","journal-title":"Mov Disord"},{"key":"2994_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2024.10.006","author":"LC Duret","year":"2024","unstructured":"Duret LC, Nagoshi E (2024) The intertwined relationship between circadian dysfunction and Parkinson\u2019s disease. Trends Neurosci. https:\/\/doi.org\/10.1016\/j.tins.2024.10.006","journal-title":"Trends Neurosci"},{"key":"2994_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4040185","author":"JY Fan","year":"2016","unstructured":"Fan JY, Chang BL, Wu YR (2016) Relationships among depression, anxiety, sleep, and quality of life in patients with Parkinson\u2019s disease in Taiwan. Parkinsons Dis https:\/\/doi.org\/10.1155\/2016\/4040185","journal-title":"Parkinsons Dis"},{"key":"2994_CR33","doi-asserted-by":"publisher","first-page":"102474","DOI":"10.1016\/j.eclinm.2024.102474","volume":"69","author":"B Feigl","year":"2024","unstructured":"Feigl B, Lewis SJG, Burr LD et al (2024) Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in parkinson\u2019s disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial. EClinicalMedicine 69:102474. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102474","journal-title":"EClinicalMedicine"},{"key":"2994_CR34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/J.PARKRELDIS.2021.02.016","volume":"85","author":"F Feng","year":"2021","unstructured":"Feng F, Cai YY, Hou YB et al (2021) Excessive daytime sleepiness in parkinson\u2019s disease: A systematic review and meta-analysis. Parkinsonism Relat Disord 85:133\u2013140. https:\/\/doi.org\/10.1016\/J.PARKRELDIS.2021.02.016","journal-title":"Parkinsonism Relat Disord"},{"key":"2994_CR35","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3233\/JPD-160886","volume":"6","author":"G Fern\u00e1ndez-Pajar\u00edn","year":"2016","unstructured":"Fern\u00e1ndez-Pajar\u00edn G, Sesar \u00c1, Ares B, Castro A (2016) Evaluating the efficacy of nocturnal continuous subcutaneous apomorphine infusion in sleep disorders in advanced parkinson\u2019s disease: the APO-NIGHT study. J Parkinsons Dis 6:787\u2013792. https:\/\/doi.org\/10.3233\/JPD-160886","journal-title":"J Parkinsons Dis"},{"key":"2994_CR36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/1073858418791763","volume":"25","author":"S Ferr\u00e9","year":"2019","unstructured":"Ferr\u00e9 S, Garc\u00eda-Borreguero D, Allen RP, Earley CJ (2019) New insights into the neurobiology of restless legs syndrome. Neuroscientist 25:113\u2013125. https:\/\/doi.org\/10.1177\/1073858418791763","journal-title":"Neuroscientist"},{"key":"2994_CR37","doi-asserted-by":"publisher","first-page":"416","DOI":"10.4103\/0972-2327.144016","volume":"17","author":"T Ferreira","year":"2014","unstructured":"Ferreira T, Prabhakar S, Kharbanda PS (2014) Sleep disturbances in drug Na\u00efve parkinson\u2019s disease (PD) patients and effect of Levodopa on sleep. Ann Indian Acad Neurol 17:416\u2013419. https:\/\/doi.org\/10.4103\/0972-2327.144016","journal-title":"Ann Indian Acad Neurol"},{"key":"2994_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S40734-015-0020-9","volume":"2","author":"G Frazzitta","year":"2015","unstructured":"Frazzitta G, Maestri R, Ferrazzoli D et al (2015) Multidisciplinary intensive rehabilitation treatment improves sleep quality in parkinson\u2019s disease. J Clin Mov Disorders 2:1\u20138. https:\/\/doi.org\/10.1186\/S40734-015-0020-9","journal-title":"J Clin Mov Disorders"},{"key":"2994_CR39","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1093\/brain\/awm222","volume":"131","author":"R Fronczek","year":"2008","unstructured":"Fronczek R, Overeem S, Lee SYY et al (2008) Hypocretin (orexin) loss and sleep disturbances in parkinson\u2019s disease. Brain 131:e88. https:\/\/doi.org\/10.1093\/brain\/awm222","journal-title":"Brain"},{"key":"2994_CR40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1179\/1743132814Y.0000000418","volume":"37","author":"RL Gama","year":"2015","unstructured":"Gama RL, De Bruin VMS, De Bruin PFC et al (2015) Risk factors for visual hallucinations in patients with parkinson\u2019s disease. Neurol Res 37:112\u2013116. https:\/\/doi.org\/10.1179\/1743132814Y.0000000418","journal-title":"Neurol Res"},{"key":"2994_CR41","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1212\/01.WNL.0000233980.25978.9D","volume":"67","author":"MD Gjerstad","year":"2006","unstructured":"Gjerstad MD, Alves G, Wentzel-Larsen T et al (2006) Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease? Neurology 67:853\u2013858. https:\/\/doi.org\/10.1212\/01.WNL.0000233980.25978.9D","journal-title":"Neurology"},{"key":"2994_CR42","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/S40675-017-0079-Y","volume":"3","author":"P Gros","year":"2017","unstructured":"Gros P, Videnovic A (2017) Sleep and circadian rhythm disorders in parkinson\u2019s disease. Curr Sleep Med Rep 3:222\u2013234. https:\/\/doi.org\/10.1007\/S40675-017-0079-Y","journal-title":"Curr Sleep Med Rep"},{"key":"2994_CR43","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/MDS.870120522","volume":"12","author":"RA Hauser","year":"1997","unstructured":"Hauser RA, Zesiewicz TA (1997) Sertraline for the treatment of depression in parkinson\u2019s disease. Mov Disord 12:756\u2013759. https:\/\/doi.org\/10.1002\/MDS.870120522","journal-title":"Mov Disord"},{"key":"2994_CR44","doi-asserted-by":"publisher","first-page":"13S","DOI":"10.5664\/JCSM.8880","volume":"16","author":"R Hoque","year":"2020","unstructured":"Hoque R (2020) Pharmacologically induced\/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM sleep behavior disorder: A worthwhile consideration. J Clin Sleep Med 16:13S\u201314S. https:\/\/doi.org\/10.5664\/JCSM.8880","journal-title":"J Clin Sleep Med"},{"key":"2994_CR45","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3390\/BIOLOGY10111205","volume":"10","author":"HT Huang","year":"2021","unstructured":"Huang HT, Huang TW, Hong CT (2021) Bright light therapy for Parkinson disease: A literature review and meta-analysis of randomized controlled trials. Biology (Basel) 10:1205. https:\/\/doi.org\/10.3390\/BIOLOGY10111205","journal-title":"Biology (Basel)"},{"key":"2994_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41531-017-0027-Z","volume":"3","author":"M Humbert","year":"2017","unstructured":"Humbert M, Findley J, Hernandez-Con M, Chahine LM (2017) Cognitive behavioral therapy for insomnia in parkinson\u2019s disease: A case series. NPJ Parkinsons Dis 3:1\u20136. https:\/\/doi.org\/10.1038\/S41531-017-0027-Z","journal-title":"NPJ Parkinsons Dis"},{"key":"2994_CR47","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1474-4422(24)00170-4","volume":"23","author":"A Iranzo","year":"2024","unstructured":"Iranzo A, Cochen De Cock V, Fantini ML et al (2024) Sleep and sleep disorders in people with parkinson\u2019s disease. Lancet Neurol 23:925\u2013937. https:\/\/doi.org\/10.1016\/S1474-4422(24)00170-4","journal-title":"Lancet Neurol"},{"key":"2994_CR48","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF03159935","volume":"14","author":"KA Jellinger","year":"1991","unstructured":"Jellinger KA (1991) Pathology of parkinson\u2019s disease\u2013 changes other than the nigrostriatal pathway. Mol Chem Neuropathol 14:153\u2013197. https:\/\/doi.org\/10.1007\/BF03159935","journal-title":"Mol Chem Neuropathol"},{"key":"2994_CR49","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/S41586-024-07108-6","volume":"627","author":"LF Jiang-Xie","year":"2024","unstructured":"Jiang-Xie LF, Drieu A, Bhasiin K et al (2024) Neuronal dynamics direct cerebrospinal fluid perfusion and brain clearance. Nature 627:157\u2013164. https:\/\/doi.org\/10.1038\/S41586-024-07108-6","journal-title":"Nature"},{"key":"2994_CR50","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/S41386-019-0444-2","volume":"45","author":"BE Jones","year":"2020","unstructured":"Jones BE (2020) Arousal and sleep circuits. Neuropsychopharmacology 45:6\u201320. https:\/\/doi.org\/10.1038\/S41386-019-0444-2","journal-title":"Neuropsychopharmacology"},{"key":"2994_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/SLEEP\/ZSAF038","volume":"XX","author":"AC Lajoie","year":"2025","unstructured":"Lajoie AC, Lafontaine A-L, Kimoff RJ et al (2025) Cognition and obstructive sleep apnea in parkinson\u2019s disease: randomized controlled trial of positive airway pressure. Sleep XX:1\u201311. https:\/\/doi.org\/10.1093\/SLEEP\/ZSAF038","journal-title":"Sleep"},{"key":"2994_CR52","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S1474-4422(18)30461-7","volume":"18","author":"Y Leng","year":"2019","unstructured":"Leng Y, Musiek ES, Hu K et al (2019) Association between circadian rhythms and neurodegenerative diseases. Lancet Neurol 18:307\u2013318. https:\/\/doi.org\/10.1016\/S1474-4422(18)30461-7","journal-title":"Lancet Neurol"},{"key":"2994_CR53","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/GPS.2472","volume":"25","author":"I Leroi","year":"2010","unstructured":"Leroi I, Baker P, Kehoe P et al (2010) A pilot randomized controlled trial of sleep therapy in parkinson\u2019s disease: effect on patients and caregivers. Int J Geriatr Psychiatry 25:1073\u20131079. https:\/\/doi.org\/10.1002\/GPS.2472","journal-title":"Int J Geriatr Psychiatry"},{"key":"2994_CR54","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/J.SLEEP.2024.01.002","volume":"114","author":"J Liang","year":"2024","unstructured":"Liang J, Wang Y, Zhu X et al (2024) Short sleep duration is associated with worse quality of life in parkinson\u2019s disease: A multicenter cross-sectional study. Sleep Med 114:182\u2013188. https:\/\/doi.org\/10.1016\/J.SLEEP.2024.01.002","journal-title":"Sleep Med"},{"key":"2994_CR55","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.sleep.2020.01.020","volume":"69","author":"C Liguori","year":"2020","unstructured":"Liguori C, Placidi F, Izzi F et al (2020) Pitolisant for treating narcolepsy comorbid with parkinson\u2019s disease. Sleep Med 69:86\u201387. https:\/\/doi.org\/10.1016\/j.sleep.2020.01.020","journal-title":"Sleep Med"},{"key":"2994_CR56","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.sleep.2021.02.036","volume":"81","author":"C Liguori","year":"2021","unstructured":"Liguori C, De Franco V, Cerroni R et al (2021) Sleep problems affect quality of life in parkinson\u2019s disease along disease progression. Sleep Med 81:307\u2013311. https:\/\/doi.org\/10.1016\/j.sleep.2021.02.036","journal-title":"Sleep Med"},{"key":"2994_CR57","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.sleep.2021.03.035","volume":"83","author":"F Lin","year":"2021","unstructured":"Lin F, Su Y, Weng Y et al (2021) The effects of bright light therapy on depression and sleep disturbances in patients with parkinson\u2019s disease: A systematic review and meta-analysis of randomized controlled trials. Sleep Med 83:280\u2013289. https:\/\/doi.org\/10.1016\/j.sleep.2021.03.035","journal-title":"Sleep Med"},{"key":"2994_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-025-00962-9","volume":"11","author":"X Ma","year":"2025","unstructured":"Ma X, Liu Y, Xie M et al (2025) Parkinson\u2019s disease with possible REM sleep behavior disorder correlated with more severe glymphatic system dysfunction. NPJ Parkinsons Dis 11:1\u20136. https:\/\/doi.org\/10.1038\/s41531-025-00962-9","journal-title":"NPJ Parkinsons Dis"},{"key":"2994_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2023.101759","author":"G Maggi","year":"2023","unstructured":"Maggi G, Vitale C, Cerciello F, Santangelo G (2023) Sleep and wakefulness disturbances in Parkinson\u2019s disease: a meta-analysis on prevalence and clinical aspects of REM sleep behavior disorder, excessive daytime sleepiness and insomnia. Sleep Med Rev. https:\/\/doi.org\/10.1016\/j.smrv.2023.101759","journal-title":"Sleep Med Rev"},{"key":"2994_CR60","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.sleep.2024.07.015","volume":"121","author":"G Maggi","year":"2024","unstructured":"Maggi G, Barone A, Mastromarino C et al (2024) Prevalence and clinical profile of patients with restless legs syndrome in parkinson\u2019s disease: A meta-analysis. Sleep Med 121:275\u2013286. https:\/\/doi.org\/10.1016\/j.sleep.2024.07.015","journal-title":"Sleep Med"},{"key":"2994_CR61","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/S10072-014-1942-Y","volume":"36","author":"CJ Mao","year":"2015","unstructured":"Mao CJ, Chen JP, Zhang XY et al (2015) Parkinson\u2019s disease patients with pain suffer from more severe non-motor symptoms. Neurol Sci 36:263\u2013268. https:\/\/doi.org\/10.1007\/S10072-014-1942-Y","journal-title":"Neurol Sci"},{"key":"2994_CR62","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3233\/JPD-2011-11037","volume":"1","author":"P Martinez-Martin","year":"2011","unstructured":"Martinez-Martin P, Reddy P, Antonini A et al (2011) Chronic subcutaneous infusion therapy with apomorphine in advanced parkinson\u2019s disease compared to conventional therapy: A real life study of Non motor effect. J Parkinsons Dis 1:197\u2013203. https:\/\/doi.org\/10.3233\/JPD-2011-11037","journal-title":"J Parkinsons Dis"},{"key":"2994_CR63","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/MDS.26067","volume":"30","author":"P Martinez-Martin","year":"2015","unstructured":"Martinez-Martin P, Reddy P, Katzenschlager R et al (2015) EuroInf: A multicenter comparative observational study of apomorphine and Levodopa infusion in parkinson\u2019s disease. Mov Disord 30:510\u2013516. https:\/\/doi.org\/10.1002\/MDS.26067","journal-title":"Mov Disord"},{"key":"2994_CR64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/MDC3.12694","volume":"6","author":"P Martinez-Martin","year":"2019","unstructured":"Martinez-Martin P, Rizos AM, Wetmore JB et al (2019) Relationship of nocturnal sleep dysfunction and pain subtypes in parkinson\u2019s disease. Mov Disord Clin Pract 6:57\u201364. https:\/\/doi.org\/10.1002\/MDC3.12694","journal-title":"Mov Disord Clin Pract"},{"key":"2994_CR65","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/570375","author":"D Martinez-Ramirez","year":"2015","unstructured":"Martinez-Ramirez D, De Jesus S, Walz R et al (2015) A polysomnographic study of Parkinson\u2019s disease sleep architecture. Parkinsons Dis. https:\/\/doi.org\/10.1155\/2015\/570375","journal-title":"Parkinsons Dis"},{"key":"2994_CR66","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.5664\/JCSM.9328","volume":"17","author":"K Maski","year":"2021","unstructured":"Maski K, Trotti LM, Kotagal S et al (2021) Treatment of central disorders of hypersomnolence: an American academy of sleep medicine clinical practice guideline. J Clin Sleep Med 17:1881\u20131893. https:\/\/doi.org\/10.5664\/JCSM.9328","journal-title":"J Clin Sleep Med"},{"key":"2994_CR67","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/MEDSCI9020031","volume":"9","author":"CE Mc Carthy","year":"2021","unstructured":"Mc Carthy CE (2021) Sleep disturbance, sleep disorders and co-morbidities in the care of the older person. Med Sci 9:31. https:\/\/doi.org\/10.3390\/MEDSCI9020031","journal-title":"Med Sci"},{"key":"2994_CR68","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00415-006-0390-x","volume":"254","author":"CAM Medeiros","year":"2007","unstructured":"Medeiros CAM, Carvalhedo De Bruin PF, Lopes LA et al (2007) Effect of exogenous melatonin on sleep and motor dysfunction in parkinson\u2019s disease: a randomized, double-blind, placebo-controlled study. J Neurol 254:459\u2013464. https:\/\/doi.org\/10.1007\/s00415-006-0390-x","journal-title":"J Neurol"},{"key":"2994_CR69","doi-asserted-by":"publisher","first-page":"104859","DOI":"10.1016\/J.NBD.2020.104859","volume":"140","author":"AA Memon","year":"2020","unstructured":"Memon AA, Coleman JJ, Amara AW (2020) Effects of exercise on sleep in neurodegenerative disease. Neurobiol Dis 140:104859. https:\/\/doi.org\/10.1016\/J.NBD.2020.104859","journal-title":"Neurobiol Dis"},{"key":"2994_CR70","doi-asserted-by":"publisher","first-page":"927994","DOI":"10.3389\/FNEUR.2022.927994","volume":"13","author":"EN Minakawa","year":"2022","unstructured":"Minakawa EN (2022) Bidirectional relationship between sleep disturbances and parkinson\u2019s disease. Front Neurol 13:927994. https:\/\/doi.org\/10.3389\/FNEUR.2022.927994","journal-title":"Front Neurol"},{"key":"2994_CR71","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4149\/BLL_2022_009","volume":"123","author":"M Minar","year":"2022","unstructured":"Minar M, Kosutzka Z, Danterova K et al (2022) Restless legs syndrome in parkinson\u2019s disease: relationship with quality of life and medication. Bratislava Med J 123:55\u201360. https:\/\/doi.org\/10.4149\/BLL_2022_009","journal-title":"Bratislava Med J"},{"key":"2994_CR72","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/MDS.28006","volume":"35","author":"A Mirelman","year":"2020","unstructured":"Mirelman A, Hillel I, Rochester L et al (2020) Tossing and turning in bed: nocturnal movements in parkinson\u2019s disease. Mov Disord 35:959\u2013968. https:\/\/doi.org\/10.1002\/MDS.28006","journal-title":"Mov Disord"},{"key":"2994_CR73","doi-asserted-by":"publisher","first-page":"405","DOI":"10.5665\/sleep.5452","volume":"39","author":"M Moccia","year":"2016","unstructured":"Moccia M, Erro R, Picillo M (2016) A four-year longitudinal study on restless legs syndrome in Parkinson disease. Sleep 39:405\u2013412","journal-title":"Sleep"},{"key":"2994_CR74","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S0079-6123(08)00929-1","volume":"172","author":"JM Monti","year":"2008","unstructured":"Monti JM, Jantos H (2008) The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking. Prog Brain Res 172:625\u2013646. https:\/\/doi.org\/10.1016\/S0079-6123(08)00929-1","journal-title":"Prog Brain Res"},{"key":"2994_CR75","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/J.SLEEP.2013.11.791","volume":"15","author":"W Moraes","year":"2014","unstructured":"Moraes W, Piovezan R, Poyares D et al (2014) Effects of aging on sleep structure throughout adulthood: a population-based study. Sleep Med 15:401\u2013409. https:\/\/doi.org\/10.1016\/J.SLEEP.2013.11.791","journal-title":"Sleep Med"},{"key":"2994_CR76","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1056\/NEJMCP2305655","volume":"391","author":"CM Morin","year":"2024","unstructured":"Morin CM, Buysse DJ (2024) Management of insomnia. N Engl J Med 391:247\u2013258. https:\/\/doi.org\/10.1056\/NEJMCP2305655","journal-title":"N Engl J Med"},{"key":"2994_CR77","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/J.PAIN.0000000000002107","volume":"162","author":"V Mylius","year":"2021","unstructured":"Mylius V, Perez Lloret S, Cury RG et al (2021) The Parkinson disease pain classification system: results from an international mechanism-based classification approach. Pain 162:1201\u20131210. https:\/\/doi.org\/10.1097\/J.PAIN.0000000000002107","journal-title":"Pain"},{"key":"2994_CR78","doi-asserted-by":"publisher","DOI":"10.1126\/SCIENCE.ABB8739","author":"M Nedergaard","year":"2020","unstructured":"Nedergaard M, Goldman SA (2020) Glymphatic failure as a final common pathway to dementia. Science. https:\/\/doi.org\/10.1126\/SCIENCE.ABB8739","journal-title":"Science"},{"key":"2994_CR79","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/MDS.29309","volume":"38","author":"A Nobileau","year":"2023","unstructured":"Nobileau A, Gaurav R, Chougar L et al (2023) Neuromelanin-sensitive magnetic resonance imaging changes in the locus coeruleus\/subcoeruleus complex in patients with typical and atypical parkinsonism. Mov Disord 38:479\u2013484. https:\/\/doi.org\/10.1002\/MDS.29309","journal-title":"Mov Disord"},{"key":"2994_CR80","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/PAPR.13352","volume":"24","author":"ACR Nogueira","year":"2024","unstructured":"Nogueira ACR, Pereira KC, Rodrigues VF et al (2024) Pain characterization in patients with parkinson\u2019s disease. Pain Pract 24:786\u2013797. https:\/\/doi.org\/10.1111\/PAPR.13352","journal-title":"Pain Pract"},{"key":"2994_CR81","doi-asserted-by":"publisher","first-page":"e894","DOI":"10.1212\/WNL.0000000000006134","volume":"91","author":"G Pagano","year":"2018","unstructured":"Pagano G, De Micco R, Yousaf T et al (2018) REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease. Neurology 91:e894\u2013e905. https:\/\/doi.org\/10.1212\/WNL.0000000000006134","journal-title":"Neurology"},{"key":"2994_CR82","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1212\/01.WNL.0000258660.74391.C1","volume":"68","author":"R Pahwa","year":"2007","unstructured":"Pahwa R, Stacy MA, Factor SA et al (2007) Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease. Neurology 68:1108\u20131115. https:\/\/doi.org\/10.1212\/01.WNL.0000258660.74391.C1","journal-title":"Neurology"},{"key":"2994_CR83","doi-asserted-by":"publisher","first-page":"e14263","DOI":"10.1111\/JSR.14263","volume":"34","author":"L P\u00e9rez-Carbonell","year":"2024","unstructured":"P\u00e9rez-Carbonell L, Iranzo A (2024) REM sleep and neurodegeneration. J Sleep Res 34:e14263. https:\/\/doi.org\/10.1111\/JSR.14263","journal-title":"J Sleep Res"},{"key":"2994_CR84","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.chest.2017.01.002","volume":"151","author":"JA Pillai","year":"2017","unstructured":"Pillai JA, Leverenz JB (2017) Sleep and neurodegeneration: A critical appraisal. Chest 151:1375\u20131386. https:\/\/doi.org\/10.1016\/j.chest.2017.01.002","journal-title":"Chest"},{"key":"2994_CR85","doi-asserted-by":"publisher","DOI":"10.1136\/BMJMENT-2024-301062","author":"S Pisani","year":"2024","unstructured":"Pisani S, Gosse L, Aarsland D et al (2024) Parkinson\u2019s disease psychosis associated with accelerated multidomain cognitive decline. BMJ Mental Health. https:\/\/doi.org\/10.1136\/BMJMENT-2024-301062","journal-title":"BMJ Mental Health"},{"key":"2994_CR86","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S1474-4422(07)70108-4","volume":"6","author":"WH Poewe","year":"2007","unstructured":"Poewe WH, Rascol O, Quinn N et al (2007) Efficacy of Pramipexole and transdermal rotigotine in advanced parkinson\u2019s disease: A double-blind, double-dummy, randomised controlled trial. Lancet Neurol 6:513\u2013520. https:\/\/doi.org\/10.1016\/S1474-4422(07)70108-4","journal-title":"Lancet Neurol"},{"key":"2994_CR87","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1212\/WNL.0B013E318263570D","volume":"79","author":"RB Postuma","year":"2012","unstructured":"Postuma RB, Lang AE, Munhoz RP et al (2012) Caffeine for treatment of Parkinson disease: A randomized controlled trial. Neurology 79:651\u2013658. https:\/\/doi.org\/10.1212\/WNL.0B013E318263570D","journal-title":"Neurology"},{"key":"2994_CR88","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.5665\/SLEEP.3102","volume":"36","author":"RB Postuma","year":"2013","unstructured":"Postuma RB, Gagnon JF, Tuineaig M et al (2013) Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal? Sleep 36:1579. https:\/\/doi.org\/10.5665\/SLEEP.3102","journal-title":"Sleep"},{"key":"2994_CR89","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/S1474-4422(18)30318-1","volume":"17","author":"MK Rasmussen","year":"2018","unstructured":"Rasmussen MK, Mestre H, Nedergaard M (2018) The glymphatic pathway in neurological disorders. Lancet Neurol 17:1016\u20131024. https:\/\/doi.org\/10.1016\/S1474-4422(18)30318-1","journal-title":"Lancet Neurol"},{"key":"2994_CR90","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.parkreldis.2015.09.025","volume":"21","author":"PL Ratti","year":"2015","unstructured":"Ratti PL, N\u00e8gre-Pag\u00e8s L, P\u00e9rez-Lloret S et al (2015) Subjective sleep dysfunction and insomnia symptoms in parkinson\u2019s disease: insights from a cross-sectional evaluation of the French CoPark cohort. Parkinsonism Relat Disord 21:1323\u20131329. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.09.025","journal-title":"Parkinsonism Relat Disord"},{"key":"2994_CR91","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1007\/S10072-023-06831-8","volume":"44","author":"SN Ravandi","year":"2023","unstructured":"Ravandi SN, Kouchaki E, Asgarian FS (2023) Prevalence of hallucinations in parkinson\u2019s patients: Meta-analysis of international studies. Neurol Sci 44:3389\u20133394. https:\/\/doi.org\/10.1007\/S10072-023-06831-8","journal-title":"Neurol Sci"},{"key":"2994_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-020-02711-z","volume":"20","author":"A Revet","year":"2020","unstructured":"Revet A, Revet A, Revet A et al (2020) Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database. BMC Psychiatry 20:1\u201313. https:\/\/doi.org\/10.1186\/s12888-020-02711-z","journal-title":"BMC Psychiatry"},{"key":"2994_CR93","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/MDS.26564","volume":"31","author":"L Ricciardi","year":"2016","unstructured":"Ricciardi L, Bove F, Espay KJ et al (2016) 24-hour infusion of levodopa\/carbidopa intestinal gel for nocturnal akinesia in advanced parkinson\u2019s disease. Mov Disord 31:597\u2013598. https:\/\/doi.org\/10.1002\/MDS.26564","journal-title":"Mov Disord"},{"key":"2994_CR94","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.parkreldis.2013.03.003","volume":"19","author":"S Rios Romenets","year":"2013","unstructured":"Rios Romenets S, Creti L, Fichten C et al (2013) Doxepin and cognitive behavioural therapy for insomnia in patients with parkinson\u2019s disease - A randomized study. Parkinsonism Relat Disord 19:670\u2013675. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.03.003","journal-title":"Parkinsonism Relat Disord"},{"key":"2994_CR95","doi-asserted-by":"publisher","first-page":"526705","DOI":"10.3389\/FNEUR.2020.00610","volume":"11","author":"A Roguski","year":"2020","unstructured":"Roguski A, Rayment D, Whone AL et al (2020) A neurologist\u2019s guide to REM sleep behavior disorder. Front Neurol 11:526705. https:\/\/doi.org\/10.3389\/FNEUR.2020.00610","journal-title":"Front Neurol"},{"key":"2994_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41531-024-00734-X","volume":"10","author":"T Rosinvil","year":"2024","unstructured":"Rosinvil T, Postuma RB, Rahayel S et al (2024) Clinical symptoms and neuroanatomical substrates of daytime sleepiness in Parkinson\u2019s disease. NPJ Parkinson\u2019s Dis 10:1\u201311. https:\/\/doi.org\/10.1038\/S41531-024-00734-X","journal-title":"NPJ Parkinson\u2019s Dis"},{"key":"2994_CR97","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.parkreldis.2017.01.015","volume":"39","author":"S Rutten","year":"2017","unstructured":"Rutten S, Vriend C, van der Werf YD et al (2017) The bidirectional longitudinal relationship between insomnia, depression and anxiety in patients with early-stage, medication-na\u00efve parkinson\u2019s disease. Parkinsonism Relat Disord 39:31\u201336. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.01.015","journal-title":"Parkinsonism Relat Disord"},{"key":"2994_CR98","doi-asserted-by":"publisher","DOI":"10.7759\/CUREUS.27821","author":"WK Saber","year":"2022","unstructured":"Saber WK, Almuallim AR, Algahtani R (2022) Restless legs syndrome and the use of antipsychotic medication: an updated literature review. Cureus https:\/\/doi.org\/10.7759\/CUREUS.27821","journal-title":"Cureus"},{"key":"2994_CR99","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.5664\/JCSM.10450","volume":"19","author":"A Scanga","year":"2023","unstructured":"Scanga A, Lafontaine AL, Kaminska M (2023) An overview of the effects of Levodopa and dopaminergic agonists on sleep disorders in parkinson\u2019s disease. J Clin Sleep Med 19:1133\u20131144. https:\/\/doi.org\/10.5664\/JCSM.10450","journal-title":"J Clin Sleep Med"},{"key":"2994_CR100","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1007\/S00415-021-10419-7","volume":"268","author":"E Schaeffer","year":"2021","unstructured":"Schaeffer E, Vaterrodt T, Zaunbrecher L et al (2021) Effects of Levodopa on quality of sleep and nocturnal movements in parkinson\u2019s disease. J Neurol 268:2506\u20132514. https:\/\/doi.org\/10.1007\/S00415-021-10419-7","journal-title":"J Neurol"},{"key":"2994_CR101","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2217\/NMT-2017-0028","volume":"7","author":"RB Schneider","year":"2017","unstructured":"Schneider RB, Iourinets J, Richard IH (2017) Parkinson\u2019s disease psychosis: presentation, diagnosis and management. Neurodegenerative Disease Manage 7:365\u2013376. https:\/\/doi.org\/10.2217\/NMT-2017-0028","journal-title":"Neurodegenerative Disease Manage"},{"key":"2994_CR102","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/J.SMRV.2016.07.002","volume":"34","author":"CV Senaratna","year":"2017","unstructured":"Senaratna CV, Perret JL, Lodge CJ et al (2017) Prevalence of obstructive sleep apnea in the general population: A systematic review. Sleep Med Rev 34:70\u201381. https:\/\/doi.org\/10.1016\/J.SMRV.2016.07.002","journal-title":"Sleep Med Rev"},{"key":"2994_CR103","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1513\/ANNALSATS.201608-625OC","volume":"14","author":"S Shafazand","year":"2017","unstructured":"Shafazand S, Wallace DM, Arheart KL et al (2017) Insomnia, sleep quality, and quality of life in mild to moderate parkinson\u2019s disease. Annals Am Thorac Soc 14:412\u2013419. https:\/\/doi.org\/10.1513\/ANNALSATS.201608-625OC","journal-title":"Annals Am Thorac Soc"},{"key":"2994_CR104","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1519\/JSC.0000000000001685","volume":"31","author":"C Silva-Batista","year":"2017","unstructured":"Silva-Batista C, De Brito LC, Corcos DM et al (2017) Resistance training improves sleep quality in subjects with moderate parkinson\u2019s disease. J Strength Conditioning Res 31:2270\u20132277. https:\/\/doi.org\/10.1519\/JSC.0000000000001685","journal-title":"J Strength Conditioning Res"},{"key":"2994_CR105","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.5665\/SLEEP.6102","volume":"39","author":"F Sixel-D\u00f6ring","year":"2016","unstructured":"Sixel-D\u00f6ring F, Zimmermann J, Wegener A et al (2016) The evolution of REM sleep behavior disorder in early Parkinson disease. Sleep 39:1737\u20131742. https:\/\/doi.org\/10.5665\/SLEEP.6102","journal-title":"Sleep"},{"key":"2994_CR200","doi-asserted-by":"publisher","unstructured":"Smilowska K, van Wamelen DJ, Bloem BR (2023) The multi-modal effect of circadian interventions in Parkinson\u2019s disease: Anarrative review.  Park Relat Disord 110:105309. https:\/\/doi.org\/10.1016\/J.PARKRELDIS.2023.105309","DOI":"10.1016\/J.PARKRELDIS.2023.105309"},{"key":"2994_CR106","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/MDC3.12279","volume":"3","author":"M Smith","year":"2015","unstructured":"Smith M, Seth J, Batla A et al (2015) Nocturia in patients with parkinson\u2019s disease. Mov Disorders Clin Pract 3:168. https:\/\/doi.org\/10.1002\/MDC3.12279","journal-title":"Mov Disorders Clin Pract"},{"key":"2994_CR107","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.parkreldis.2015.11.003","volume":"23","author":"J Sringean","year":"2016","unstructured":"Sringean J, Taechalertpaisarn P, Thanawattano C, Bhidayasiri R (2016) How well do parkinson\u2019s disease patients turn in bed? Quantitative analysis of nocturnal hypokinesia using multisite wearable inertial sensors. Parkinsonism Relat Disord 23:10\u201316. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.11.003","journal-title":"Parkinsonism Relat Disord"},{"key":"2994_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/SLEEP\/ZSAB067","volume":"44","author":"J Sringean","year":"2021","unstructured":"Sringean J, Stefani A, Marini K et al (2021) Rapid eye movement sleep behavior disorder and rapid eye movement sleep without Atonia are more frequent in advanced versus early parkinson\u2019s disease. Sleep 44:1\u20138. https:\/\/doi.org\/10.1093\/SLEEP\/ZSAB067","journal-title":"Sleep"},{"key":"2994_CR109","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/J.JNS.2017.07.045","volume":"380","author":"K Suzuki","year":"2017","unstructured":"Suzuki K, Miyamoto M, Miyamoto T et al (2017) Istradefylline improves daytime sleepiness in patients with parkinson\u2019s disease: an open-label, 3-month study. J Neurol Sci 380:230\u2013233. https:\/\/doi.org\/10.1016\/J.JNS.2017.07.045","journal-title":"J Neurol Sci"},{"key":"2994_CR110","doi-asserted-by":"publisher","first-page":"108436","DOI":"10.1016\/j.clineuro.2024.108436","volume":"244","author":"DM Tam","year":"2024","unstructured":"Tam DM, Linh LTT, Trang DT, Ha T, An T (2024) Sleep disturbances and associated factors in patients with parkinson\u2019s disease. Clin Neurol Neurosurg 244:108436. https:\/\/doi.org\/10.1016\/j.clineuro.2024.108436","journal-title":"Clin Neurol Neurosurg"},{"key":"2994_CR111","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1212\/WNL.0000000000003540","volume":"88","author":"LK Tholfsen","year":"2017","unstructured":"Tholfsen LK, Larsen JP, Schulz J et al (2017) Changes in insomnia subtypes in early Parkinson disease. Neurology 88:352\u2013358. https:\/\/doi.org\/10.1212\/WNL.0000000000003540","journal-title":"Neurology"},{"key":"2994_CR112","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000208028","author":"MH Tosin","year":"2024","unstructured":"Tosin MH, Goetz CG, Stebbins GT (2024) Patient with Parkinson disease and care partner perceptions of key domains affecting health-related quality of life. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000208028","journal-title":"Neurology"},{"key":"2994_CR113","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/MDS.23441","volume":"26","author":"C Trenkwalder","year":"2011","unstructured":"Trenkwalder C, Kies B, Rudzinska M et al (2011) Rotigotine effects on early morning motor function and sleep in parkinson\u2019s disease: A double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord 26:90\u201399. https:\/\/doi.org\/10.1002\/MDS.23441","journal-title":"Mov Disord"},{"key":"2994_CR114","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/NAU.22365","volume":"32","author":"CP Vaughan","year":"2013","unstructured":"Vaughan CP, Juncos JL, Trotti LM et al (2013) Nocturia and overnight polysomnography in Parkinson disease. Neurourol Urodyn 32:1080\u20131085. https:\/\/doi.org\/10.1002\/NAU.22365","journal-title":"Neurourol Urodyn"},{"key":"2994_CR115","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/JAMANEUROL.2016.5192","volume":"74","author":"A Videnovic","year":"2017","unstructured":"Videnovic A, Klerman EB, Wang W et al (2017) Timed light therapy for sleep and daytime sleepiness associated with Parkinson disease: A randomized clinical trial. JAMA Neurol 74:411\u2013418. https:\/\/doi.org\/10.1001\/JAMANEUROL.2016.5192","journal-title":"JAMA Neurol"},{"key":"2994_CR116","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/EJP.2096","volume":"27","author":"FJF Viseux","year":"2023","unstructured":"Viseux FJF, Delval A, Simoneau M, Defebvre L (2023) Pain and parkinson\u2019s disease: current mechanisms and management updates. Eur J Pain (United Kingdom) 27:553\u2013567. https:\/\/doi.org\/10.1002\/EJP.2096","journal-title":"Eur J Pain (United Kingdom)"},{"key":"2994_CR117","doi-asserted-by":"publisher","DOI":"10.1093\/SLEEPADVANCES\/ZPAE079","author":"A Wadhwa","year":"2024","unstructured":"Wadhwa A, Pacheco-Barrios N, Tripathy S et al (2024) The effects of deep brain stimulation on sleep: a systematic review and meta-analysis. Sleep Adv. https:\/\/doi.org\/10.1093\/SLEEPADVANCES\/ZPAE079","journal-title":"Sleep Adv"},{"key":"2994_CR118","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/MDC3.12899","volume":"7","author":"DM Wallace","year":"2020","unstructured":"Wallace DM, Wohlgemuth WK, Trotti LM et al (2020) Practical evaluation and management of insomnia in parkinson\u2019s disease: A review. Mov Disorders Clin Pract 7:250\u2013266. https:\/\/doi.org\/10.1002\/MDC3.12899","journal-title":"Mov Disorders Clin Pract"},{"key":"2994_CR201","doi-asserted-by":"publisher","unstructured":"Willis G, Endo T, Waldman M (2024) Circadian intervention improves Parkinson\u2019s disease and may slow disease progression: A ten-year retrospective study. Brain Sci 14:1218. https:\/\/doi.org\/10.3390\/BRAINSCI14121218\/S1","DOI":"10.3390\/BRAINSCI14121218\/S1"},{"key":"2994_CR119","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5664\/JCSM.11390","volume":"21","author":"JW Winkelman","year":"2025","unstructured":"Winkelman JW, Berkowski JA, DelRosso LM et al (2025) Treatment of restless legs syndrome and periodic limb movement disorder: an American academy of sleep medicine clinical practice guideline. J Clin Sleep Med 21:137\u2013152. https:\/\/doi.org\/10.5664\/JCSM.11390","journal-title":"J Clin Sleep Med"},{"key":"2994_CR120","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/S00415-020-10140-X","volume":"268","author":"Z Xu","year":"2021","unstructured":"Xu Z, Anderson KN, Saffari SE et al (2021) Progression of sleep disturbances in parkinson\u2019s disease: A 5-year longitudinal study. J Neurol 268:312\u2013320. https:\/\/doi.org\/10.1007\/S00415-020-10140-X","journal-title":"J Neurol"},{"key":"2994_CR121","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/S11910-022-01223-5","volume":"22","author":"Z Xu","year":"2022","unstructured":"Xu Z, Anderson KN, Pavese N (2022) Longitudinal studies of sleep disturbances in parkinson\u2019s disease. Curr Neurol Neurosci Rep 22:635\u2013655. https:\/\/doi.org\/10.1007\/S11910-022-01223-5","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2994_CR122","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jocn.2018.06.016","volume":"54","author":"F Xue","year":"2018","unstructured":"Xue F, Wang FY, Mao CJ et al (2018) Analysis of nocturnal hypokinesia and sleep quality in parkinson\u2019s disease. J Clin Neurosci 54:96\u2013101. https:\/\/doi.org\/10.1016\/j.jocn.2018.06.016","journal-title":"J Clin Neurosci"},{"key":"2994_CR123","doi-asserted-by":"publisher","first-page":"709878","DOI":"10.3389\/FNAGI.2021.709878","volume":"13","author":"J Yan","year":"2021","unstructured":"Yan J, Liu A, Huang J et al (2021) Pharmacological interventions for REM sleep behavior disorder in parkinson\u2019s disease: A systematic review. Front Aging Neurosci 13:709878. https:\/\/doi.org\/10.3389\/FNAGI.2021.709878","journal-title":"Front Aging Neurosci"},{"key":"2994_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-022-00303","volume":"8","author":"G Ye","year":"2022","unstructured":"Ye G, Xu X, Zhou L et al (2022) Evolution patterns of probable REM sleep behavior disorder predicts parkinson\u2019s disease progression. NPJ Parkinsons Dis 8:1\u20138. https:\/\/doi.org\/10.1038\/s41531-022-00303","journal-title":"NPJ Parkinsons Dis"},{"key":"2994_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/S41531-020-00126-X","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhao JH, Huang DY et al (2020) Multiple comorbid sleep disorders adversely affect quality of life in parkinson\u2019s disease patients. NPJ Parkinson\u2019s Disease. 610.1038\/S41531-020-00126-X","journal-title":"NPJ Parkinson\u2019s Disease"},{"key":"2994_CR126","doi-asserted-by":"publisher","first-page":"128077","DOI":"10.1016\/j.micres.2025.128077","volume":"293","author":"W Zhu","year":"2025","unstructured":"Zhu W, Hu Y, Shi Y et al (2025) Sleep deprivation accelerates parkinson\u2019s disease via modulating gut microbiota-associated microglial activation and oxidative stress. Microbiol Res 293:128077. https:\/\/doi.org\/10.1016\/j.micres.2025.128077","journal-title":"Microbiol Res"},{"key":"2994_CR127","doi-asserted-by":"publisher","DOI":"10.4103\/JRMS.JRMS_790_21","author":"E Ziaei","year":"2022","unstructured":"Ziaei E, Ardestani PE, Chitsaz A (2022) Comparison of pramipexole and citalopram in the treatment of depression in Parkinson\u2019s disease: a randomized parallel-group trial. J Res Med Sci. https:\/\/doi.org\/10.4103\/JRMS.JRMS_790_21","journal-title":"J Res Med Sci"},{"key":"2994_CR128","doi-asserted-by":"publisher","DOI":"10.1111\/ANE.12075","author":"M Zibetti","year":"2013","unstructured":"Zibetti M, Rizzone M, Merola A et al (2013) Sleep improvement with levodopa\/carbidopa intestinal gel infusion in Parkinson disease. Acta Neurol Scand. https:\/\/doi.org\/10.1111\/ANE.12075","journal-title":"Acta Neurol Scand"},{"key":"2994_CR129","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/S00415-017-8491-2","volume":"264","author":"M Zibetti","year":"2017","unstructured":"Zibetti M, Romagnolo A, Merola A et al (2017) A polysomnographic study in parkinsonian patients treated with intestinal Levodopa infusion. J Neurol 264:1085\u20131090. https:\/\/doi.org\/10.1007\/S00415-017-8491-2","journal-title":"J Neurol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02994-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-025-02994-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02994-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:44:30Z","timestamp":1763563470000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-025-02994-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":131,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2994"],"URL":"https:\/\/doi.org\/10.1007\/s00702-025-02994-0","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}